FDA OK's Genetically Engineered Drug for Bleeding Disorder
(MedPage Today) -- Vonvendi is first recombinant von Willebrand factor replacement product
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Bleeding | Genetics | Health | International Medicine & Public Health | von Willebrand Disease